Dr. Fulmer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44106
Summary
- Dr. Clifton Fulmer is a pathologist in Cleveland, OH and is affiliated with multiple hospitals in the area, including the Cleveland Clinic. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 1 year. He specializes in gastrointestinal & hepatobiliary pathology, anatomic pathology, and surgical pathology.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2015 - 2019
Rutgers Robert Wood Johnson Medical SchoolClass of 2015
Graduate School of Biomedical Sciences, Rutgers UniversityPhD, Neuroscience and Cell Biology, 2007 - 2013
Certifications & Licensure
NY State Medical License 2017 - 2026
OH State Medical License 2019 - 2025- American Board of Pathology Pathology - Anatomic
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- 30 citationsInsulin-like growth factor-I-stimulated Akt phosphorylation and oligodendrocyte progenitor cell survival require cholesterol-enriched membranes.Robert J. Romanelli, Kedar R Mahajan, Clifton G. Fulmer, Teresa L. Wood
Journal of Neuroscience Research. 2009-11-15 - 11 citationsA phase IB/IIA study of remestemcel-L, an allogeneic bone marrow-derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: a...Amy L Lightner, Neda Dadgar, Caroline Matyas, Kavita Elliott, Clifton Fulmer
Colorectal Disease. 2022-11-01 - 3 citationsMesenchymal Stem Cell Extracellular Vesicles as a New Treatment Paradigm in Solid Abdominal Organ Transplantation: A Case Series.Amy L Lightner, Masato Fujiki, Mohamed Elshawy, Neda Dadgar, Anita Barnoski
Stem Cells and Development. 2024-03-01
Journal Articles
- CD30 + T Cell Enriched Primary Cutaneous CD4 + small/medium Sized Pleomorphic T Cell Lymphoma: A Distinct Variant of Indolent CD4 + T Cell Lymphoproliferative DiseaseClifton Fulmer, MD, ScienceDirect
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
